Tafenoquine for Relapsing Babesiosis: A Case Series.
Peter J KrauseRalph RogersMonika K ShahHeeEun KangJeffrey ParsonnetRich KodamaEdouard VannierPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)
Tafenoquine can be a useful adjunct for the treatment of highly immunocompromised patients experiencing relapsing babesiosis caused by B. microti.